First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
AbbVie
AbbVie
AstraZeneca
Regeneron Pharmaceuticals
Seagen Inc.
Shattuck Labs, Inc.
Transgene
SystImmune Inc.
Mersana Therapeutics
Volastra Therapeutics, Inc.
Sutro Biopharma, Inc.
Toray Industries, Inc
Arsenal Biosciences, Inc.
Lyell Immunopharma, Inc.
Bio-Path Holdings, Inc.
Shattuck Labs, Inc.
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Precigen, Inc
Imunon
Kazia Therapeutics Limited
Hoffmann-La Roche
ADC Therapeutics S.A.
Kyowa Kirin Co., Ltd.
Celldex Therapeutics
Instil Bio
Gilead Sciences
Xencor, Inc.
Xencor, Inc.
EMD Serono
Array BioPharma
Mereo BioPharma
Mereo BioPharma
Celgene
Celgene
Lee's Pharmaceutical Limited
Critical Outcome Technologies Inc.
Merck Sharp & Dohme LLC
Oncolix, Inc.
AbbVie
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Santa Maria Biotherapeutics
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Merck Sharp & Dohme LLC
TetraLogic Pharmaceuticals
Amgen
Merck Sharp & Dohme LLC
Genentech, Inc.